Jun Su
Bristol-Myers Squibb
6 Papers
Jun Su is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Serum miR-21 predicts the prognosis of patients with primary gastrointestinal diffuse large B-cell lymphoma.
Qing Ji,Ting Zhang Jing Cheng Jingying Xiang Jie Jiang,Jun Su,Su-Yuan Zhang,Cheng-Fang Li,Xiao-Rong Yang,Xinglong Wu,Jin Yao,Dan Yuan,Jin-Jing Wang +9 more
TL;DR: It is suggested that microRNA (miR)-21 is a potential prognostic marker to predict clinical outcomes in PGI-DLBCL patients and a high miR-21 level is associated with poor outcomes.
4
Off-label dose direct oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation: A new evidence of Asian dose.
Wenlin Xu,Meina Lv,Tingting Wu,Nianxu Huang,Wang Zhang,Jun Su,Hengfen Dai,Ping Gu,Xiaohong Huang,X. Du,Ruijuan Li,Qi Zheng,Yuxin Liu,Jinghui Zhang,Xiu-Qin Liu,Zhu Zhu,Jinghuai Zhang +16 more
TL;DR: Off-label underdose DOACs were associated with significantly lower risks of major bleeding, all-cause death, and similar risks of minor bleeding, thrombotic events compared with on-label doseDOACs.
3
Willis covered stent treatment for blood blister-like aneurysm: A meta-analysis of efficacy and safety
Jiahe Tan,Ruipeng Song,Si Luo,W. Fu,Jun Su,Zhaohui He +5 more
TL;DR: In this article , a systematic literature review was performed using a comprehensive literary search in Medline, Embase, and Web of Science databases to identify studies related to Willis Covered Stent (WCS) treatment for BBA.
2
Incidence and Costs of Treatment-Related Complications Among Patients With Advanced Squamous Cell Carcinoma of the Head and Neck
Kathleen Lang,Matthew Sussman,Mark Friedman,Jun Su,H. Kan,David J. Mauro,David J. Mauro,Eskinder Tafesse,Eskinder Tafesse,Joseph Menzin +9 more
TL;DR: The study results suggest that the attributable incidence and costs of treatment-related complications associated with chemotherapy in ASCCHN are substantial and the emergence of safer treatments may have the advantage of alleviating this cost burden.
Epidemiology of Cardiopulmonary Arrest and Outcome of Resuscitation in PICU Across China: A Prospective Multicenter Cohort Study
Xin Ding,Gang Liu,Su Yun Qian,Jiansheng Zeng,Ying Wang,Jianping Chu,Qing Chen,Jian-li Chen,Yuanyuan Duan,Danqun Jin,Jiaotian Huang,Xiulan Lu,Yanmei Guo,Xiaona Shi,Ximin Huo,Jun Su,Yi-nuo Cheng,Y Yin,Xiaowei Xin,Zheng-yun Sun,Shaodong Zhao,Hongjun Miao,Zixuan Lou,Jun Li,Jinghui Jiang,S. Dong +25 more
TL;DR: Wang et al. as discussed by the authors investigated the epidemiology and the effectiveness of resuscitation from cardiopulmonary arrest (CPA) among critically ill children and adolescents during pediatric intensive care unit (PICU) stay across China.